APA (7th ed.) Citation

Bakos, G., Bauder-Wüst, U., Landry, J., Roscher, M., Ramasz, B., Bruchertseifer, F., . . . Benešová-Schäfer, M. (2026). EpCAM-PSMA: Potential predictors of treatment outcomes for PSMA-targeted alpha therapies in metastatic castration-resistant prostate cancer. Molecular therapy. Oncology, 34(1), . https://doi.org/10.1016/j.omton.2026.201143

Chicago Style (17th ed.) Citation

Bakos, Gábor, et al. "EpCAM-PSMA: Potential Predictors of Treatment Outcomes for PSMA-targeted Alpha Therapies in Metastatic Castration-resistant Prostate Cancer." Molecular Therapy. Oncology 34, no. 1 (2026). https://doi.org/10.1016/j.omton.2026.201143.

MLA (9th ed.) Citation

Bakos, Gábor, et al. "EpCAM-PSMA: Potential Predictors of Treatment Outcomes for PSMA-targeted Alpha Therapies in Metastatic Castration-resistant Prostate Cancer." Molecular Therapy. Oncology, vol. 34, no. 1, 2026, https://doi.org/10.1016/j.omton.2026.201143.